|
1. When does the follow-up start?
|
- Check if the authors report the start of follow-up. It might be called the baseline, index date, and time zero.
|
|
2. When do individuals complete eligibility?
|
- Check if authors report when individuals should complete eligibility.
|
|
2.a. Can individuals be eligible at multiple times?
|
- Check if individuals could be eligible at multiple times and whether authors used a strategy to overcome this: (1) choose a single eligible time and (2) choose all eligible times and conduct a sequence of trials at each eligible time.
|
|
2.b. Is there any post-baseline event (i.e., an event after the follow-up starts) in the eligibility criteria?
|
- Check if any events after the start of follow-up are listed in the eligibility criteria, e.g., complete 2 consecutive prescriptions or no outcome for the first 2 months after the start of follow-up.
|
|
3. When are individuals assigned to an exposed or non-exposed group?
|
- Check if the authors report clearly when individuals are classified as exposed or non-exposed group.
|
|
3a. Do individuals have to use treatment for a given period to be classified as an exposed group?
|
- Check if individuals have to use treatment for a given period, e.g., complete 2 consecutive prescriptions to be classified as exposed and non-exposed, if not, start the treatment or complete only 1 prescription.
|
|
3.b. Is there a grace period?
|
- Check if individuals can start the treatment sometime after the start of follow-up and eligibility.
|
